![]() NextPoint Therapeutics NextPoint Therapeutics is a biotechnology company that develops precision immuno-oncology. | ![]() Immunicom Immunicom is a company that develops and commercializes a non-drug-based cancer therapy in order to reduce treatment side effects and enhance its response rates. | bioAffinity Technologies bioAffinity Technologies is a company focusing on the diagnosis of early-stage cancer, diseases of the lung, and targeted cancer treatment. | |||
Founding Date | Founding Date 2018 | Founding Date 2013 | Founding Date 2008 | Founding Date 2014 | Founding Date 2014 |
Type | Type Private | Type Private | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Cambridge, US HQ Cambridge, US | Locations San Diego, US HQ | Locations Tres Cantos, ES HQ Tres Cantos, ES | Locations Paris, FR HQ | Locations San Antonio, US HQ San Antonio, US |
Employees | Employees 41 | Employees 22 | Employees 23 | Employees 12 | Employees 11 |
Funding | |||||
Latest funding round | Latest funding round $ 80m (over 3 years ago) | Latest funding round $ 1.9m (over 6 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 80m | Total funding raised $ 21.9m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 4.2m |

Immunicom is a company that develops and commercializes a non-drug-based cancer therapy in order to reduce treatment side effects and enhance its response rates.
View company
Mecwins is a company developing technology for nanomechanical sensing.
View company
Feroscan is a company specializing in the development of personalized cytotoxics.
View companybioAffinity Technologies is a company focusing on the diagnosis of early-stage cancer, diseases of the lung, and targeted cancer treatment.
View company